Acima Private Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
BVL
CIM
IWS
NAM
Acima Private Wealth's BIIB Position: Q3 2026 in Review
Acima Private Wealth reduced its Biogen (BIIB) stake by 9% in Q3 2026, selling an estimated $17.4K and leaving 834 shares worth $188K. The position accounts for 0.05% of the portfolio, ranked #113.
Acima Private Wealth first reported a position in BIIB in Q4 2018 and has held it in 32 quarters since. The position peaked at $317K in Q2 2021. 77 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Acima Private Wealth held 834 shares of Biogen worth $188K as of Q3 2026.
- Acima Private Wealth sold 82 Biogen shares in Q3 2026, an estimated $17.4K.
- Biogen made up 0.05% of Acima Private Wealth's portfolio in Q3 2026, its #113 holding.
- Acima Private Wealth first reported a position in Biogen in Q4 2018 and has held it in 32 quarters since.
- Acima Private Wealth's Biogen position peaked at $317K in Q2 2021.
- 77 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Acima Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.